These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21393359)

  • 1. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).
    Kuo CC; Wu VC; Huang KH; Wang SM; Chang CC; Lu CC; Yang WS; Tsai CW; Lai CF; Lee TY; Lin WC; Wu MS; Lin YH; Chu TS; Lin CY; Chang HW; Wang WJ; Kao TW; Chueh SC; Wu KD; Taipai Study Group
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):348-57. PubMed ID: 21393359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
    Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
    J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
    Berge C; Courand PY; Harbaoui B; Paget V; Khettab F; Bricca G; Fauvel JP; Lantelme P
    J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F; Mattarello MJ; Albiger NM
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
    Zuo FJ; Zhou XH; Ren Y; Chen T; Tian HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of midnight 1 mg dexamethasone suppression test combined with ACTH stimulation test in the diagnosis of primary aldosteronism subtypes].
    Qiu P; Zhang L; Jiang DY; Zang L; Guo QH; Lyu ZH; Mu YM
    Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(24):2242-2248. PubMed ID: 38901981
    [No Abstract]   [Full Text] [Related]  

  • 14. Aldosterone and refractory hypertension: a prospective cohort study.
    Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
    Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
    Chen KM; Lee BC; Chen PT; Liu KL; Lin KH; Chang CC; Wu TH; Hong JS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():647184. PubMed ID: 34335463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
    Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
    Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal damage in primary aldosteronism: results of the PAPY Study.
    Rossi GP; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mannelli M; Matterello MJ; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Pessina AC; Mantero F;
    Hypertension; 2006 Aug; 48(2):232-8. PubMed ID: 16801482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.
    Omura M; Sasano H; Saito J; Yamaguchi K; Kakuta Y; Nishikawa T
    Hypertens Res; 2006 Nov; 29(11):883-9. PubMed ID: 17345788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.